Setmelanotide

Also known as: RM-493

MC4R agonist for appetite research

What is Setmelanotide?

Setmelanotide, also known as RM-493, is a synthetic peptide classified under fat loss and metabolic peptides. It acts primarily as an agonist of the melanocortin-4 receptor (MC4R), which plays a crucial role in regulating appetite and energy expenditure. This peptide is particularly significant in research focused on obesity and metabolic disorders.

Setmelanotide is designed to mimic the natural hormone alpha-melanocyte-stimulating hormone (α-MSH), which interacts with the MC4R to influence feeding behavior and body weight regulation. Its unique mechanism makes it a valuable tool in understanding appetite control and metabolic processes.

How It Works

Setmelanotide functions by binding to the melanocortin-4 receptor (MC4R) in the brain, which is a key player in the central nervous system's regulation of appetite and energy balance. When activated, this receptor helps to suppress hunger signals, thereby reducing food intake and promoting weight loss.

Mechanism of Action

The peptide's action leads to increased energy expenditure and altered metabolic pathways, contributing to its potential effectiveness in managing obesity. By mimicking the effects of natural melanocortins, Setmelanotide helps to restore the signaling pathways that may be disrupted in individuals with certain genetic obesity syndromes.

Research Uses

  • Obesity Management

    Investigated for its role in treating obesity related to genetic disorders affecting MC4R signaling.
  • Appetite Regulation

    Studied for its effects on appetite suppression and energy balance in various populations.
  • Metabolic Disorders

    Explored in the context of metabolic syndrome and related conditions.

Effects

  • Appetite Suppression

    Research indicates significant reductions in appetite and caloric intake among subjects.
  • Weight Loss

    Observed outcomes include notable weight loss in individuals with MC4R deficiency.
  • Improved Metabolic Health

    Users report enhancements in metabolic parameters, including insulin sensitivity.

Summary

Setmelanotide serves as a potent MC4R agonist, making it a critical focus in appetite and metabolic research. Its ability to influence appetite regulation positions it as a valuable compound in the study of obesity and metabolic disorders.

Last updated: Feb 25, 2026